Dr. Vi Kien Chiu, MD, PhD

Dr. Chiu practices at Cedars-Sinai Medical Care Foundation in Beverly Hills, California.

Dr. Chiu's NPI, 1992725865, was assigned on July 20, 2006. Dr. Chiu graduated from New York University School of Medicine in 2002. Dr. Chiu's California license number on file is A120131.

Dr. Chiu's primary practice is Cedars-Sinai Medical Care Foundation, at 8501 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 385-3200.

Dr. Chiu's primary practice is Cedars-Sinai Medical Care Foundation in Beverly Hills, California. Dr. Chiu is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Chiu to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chiu practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Chiu's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Chiu is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Chiu's licenses on file in 5 states: California, New Mexico, New Jersey, New York and Pennsylvania.

Dmand AI lists chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lymphoma and neutropenia among the conditions Dr. Chiu treats.

CMS data shows 20,237 Medicare services from Dr. Chiu across 28 procedure codes in 2024, for 140 Medicare patients. Medicare paid $104,740 for them.

CMS counts 140 Medicare patients who saw Dr. Chiu in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chiu's median patient age at 71, with 50% women.

In 2024, Dr. Chiu wrote 234 Medicare Part D claims for 43 patients. 67% of them were for generic drugs. CMS names the drug for 87 of them, across 5 drugs with 11 or more claims each, at $455,447 in total drug cost. In 2023, CMS named 235 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Chiu for performance year 2024, reported as part of a group. Dr. Chiu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Chiu, published from 2014 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Antibodies, Monoclonal, Humanized. Dr. Chiu has published most often in J Clin Oncol. Dr. Chiu's most frequent co-authors are Eugene R. Ahn, MD, Deepti Behl, MD and Richard L. Schilsky, MD.

Dmand AI links Dr. Chiu to 11 clinical trials, 5 of them phase 2 studies. 8 are still active or recruiting. Conditions studied include Pancreatic Neoplasms, Rectal Diseases and Colorectal Neoplasms. National Cancer Institute (NCI) sponsors the most, 4. Open Payments lists research payments to Dr. Chiu that name 1 trial.

CMS Open Payments shows 11 general payments to Dr. Chiu from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 97% of the total. AstraZeneca Pharmaceuticals LP paid the most, $280. It also lists 1 research payment totaling $2,213 in 2018, naming 1 clinical trial.

Dr. Chiu graduated from New York University School of Medicine in 2002. Dr. Chiu is a member of AACR and ASCO.

Dr. Chiu is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.